Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-07

Clinical Trial Update: Study of Bortezomib +HSCT in Primary Systemic Amyloidosis (AL) [NA]

View source ↗

Summary

This document notes the completion of a clinical trial evaluating the combination of bortezomib with hematopoietic stem cell transplantation for primary systemi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Velcade (bortezomib) (bortezomib)

Snippet

Sponsor: Zhi-Hong Liu, M.D. | Conditions: Amyloidosis | NA | Status: COMPLETED